}ks8eK'^~˖sǙlxlg2{\DBaEjƭ:/xPԃzT"&Ѝn x̶ox9#Gnm?=z?/H7yx n wh6-_؟C؜}gQӴo$L5\˵\c[NÂƚ@V>04b.>ۻ$di #t-RMdK]FO"yvEo &oਢ"J. B5ׯm`F%FQfin8OEO#E؛&s;tcp:G$YӊרQUjAهo yP,}2`v;~!*_7$(oxG"xݼg_"a%7۲C= ʺ4̣v{n }cŇ(%t%d  ˴h5H0 s~,]v<,Ϋ/{DCy}q3g0ɝ0䱤Mg XX%|F@NbckD]Bp{'Kiͨ`uXKR ?[Œu ʱa@(ks(F\6C1lX (q6xG{*aiFwEoBھF4JF`hdi =`u$˱ G֗7ay)w;XIg[;EeFZa%8eWq{ΐUwv"HB~g4k,&`%S J3'T-N[o'M*qIQQ(Up&+&$7kRy̜h$R. @Y GB(% t:kϚ>֌^DZ5DM \ ԝQE!ϟGȁyk0)c(T;.p3D>x51GK0/`!}PƁ #ԃ:G8zfpVupc#,[Wҹnh:KHDonnGn6fB "НƁ(#< )@"MVb(m Eo@R;zgм~_™q6ܒ5ԊmPxwfL#I){W7`IduDh)TGsI(uxl+疙%ȊP T̻ ] ô -Ŭ(xh 0R$8H fP U/{QV+,fct1i;_i!XEdECmT U I޼ؐӸ R<9JM cyclhCv[TC~áB=ѨT/ IC&m;ڵ$,+'G:"0(= ,i`Bڗ 0BCJv x@QXUmlv*)];U4ޣ'7acs܁Bj]HH:{voVDբQa,J.<[d%D,JwMwcC%Dyu6"J c40| Fl: ndWK!+8"~@ڣBM"`'ȡo1 ڸahK# >izU+Yܰ>JBq @n{/C7ۍgӀ!LxF"(ǀ 6V, S^080AMFFcI*a(߂8AyY +kXRl _^)UW2%m2NY R;G5fR@NR~,A4;pRFݦ@vGzvƐ$=^@zs'OuXM^풗>|9H]ȣ  iZ minM:~,NkۯjSڣxl0%+37xtPSwS ev$bks@~~C D]Pwa/ @_*PXl vIP>OUTa40wvB`I9f\-WtBHc. $=vIJY)<{sv.ZPW]4AkQ$'EJf+CP$Fss!}/V-Tdb <5VP/ow7 MM&$GIbp JD얡}MJ-[+m|6AZJ'7'=0,[0?`84wkox)Lvw0JO+W''7*OeH xG&/EZ tbW/TS?m[11vJ^a7C'Ih[j ؀ 䊠'3X`?hgãnܒ3}rFl.CqJ ~Dvdzh6!,D Ra~ T*`m׶O:&NKQSՃ`&T"DTX?t"R1po1WR=G&MtH!J=Vyƃ3e"YI)VoDA(}WзELֳQK.(Yƒ)WW7RH꾩 >⼆)%.4t ଳppL1\Vc&<] S3p}kj,a6#"XmlXȄ u4he#xaXYWGP7QaXRƞUڝq5?f͹V-F1U8cd-.̭74);daFc,K9jƴ2Ehbfyb."•0`k)cy LcݖQWVjXNZ}`ǮPKlmԫQe{=G]@7rs࿔l~5mfMO'Ǵj=V9ap[Z "kE?jg=Y;)Ev&3JЅf;J ށZ eP>ILFe$qKIEl;Bt ܤ>wB@OCCPgfn2! s$LuhjuQbdVMvȥ` It7)͋1WVTIW˭ %ܡ!Vmҥ}`x6{H:ri []b[]aEM-2ՌN-ɑO8iL0~|{ U1C>w6XϮm-v_QG*?o*usArD7Gt.W8@y1̊u|ȕ.:P`ml &MFշJJ'dM NH(HSr׺py7W Ĉ8NEl!)y[u_/<tI16@ M?z e(aIBRyR]nܣh@@x3֌Q `y{- dVHlOg. I8gRsi;_#By/s\XT9DoPWN}R7vb2\b%uTqrވ-1=QxW^Dϝ^}g{D$Mz_X(|l9+{ty+JC^Rz3o7\ž'\mK4zJiP+ت%1`%\/78`q%9b 鐜*qgw8~y(ۛs!;U)eB6X wpټ؃AFVa_Dr7R l!yLcq@;9W|暬6SP~Ft~*8[#J՜=6⾍>@rKnISYAޤ*[ɗ i 54G= *45ٰa-,Z@ܐh-D:g3 .\G8hs kYfR{ Ĝ6_ٱ >N Yir!Q9[lpyowE/!RdUo|gJ֦2(ȫ'/Qϳ{j/z6q):+21鹆%I8ܭFTHTD甲kE~JjVp!U5+88*[_S!;NB~{4|5m9 E1$Sj*R4O&ʉd*a>a+c$ j@ f,pH6[: xDͮZe%5/Sf *y8\ipECWHuZ3YPYCM'[W5O:Uj3x 8׶iDY6Lz gHc}g@x];*Θ=2p&Vy_ cڢ>˵]:,C\jp^ 8؆4S87ϚA13w+Yb3  pMIL0ݛYU+PqPN9p'h!P,"2! 6”"FC>Kdhװp# ?oe$֒s6zٵeqr#n9ix:#V? 7 fԭ&S$Rx+aycXeFJ*XLcQ]m2G׫r};%G sG$|'25G`=FG9*w.d|QCE9*_~TPqul|cEvbT=Pρz |ʕ?x||rQmu||~̣N]KR9K)_c%qOHZ_0wr?(WaAgcnVN'T:(?G;2/^?@|Qg=A9?H|q|rQw?'_{O?P\)˞Q;cu:cl>+']dc"bauE鏄Q F~CO+o@%ڊy`SKu> O-d4p#UmC t%RpOo0Xnԧ/V_Q@4Gm<7d: DŽ~oe`;>~?6r0j,:1oU$a^'XgP0[>:WX: i-{iZWxg!ckGj F0&BF}(z4BfJ NOF.`s#^WPXaB}1"=T%pM9~~r229T &IhG }mZnrsr*ukcrll#h<$?3E]rW+Ȉf$qVP<wc|S@EzS9fI3pP6>Y}s:Y[3k{=(lT<c~ *3bԶbD$OF耆c1KZ~wH.eT6N><˱:_F;L:ɉjQ6>W $AbؿS9i Ivljˮq+B+,;"\Jt8zlԡϘ2n$Rf[zVbrnjUu*m~;hh`O  8TP0ۼ _ 1:#}̙ NYq P WQKQ+oۧȕVs!goZ\[|p* IubJ{v% gl0x@&45 Ø Huss1j3hS9|w ].7>yE1`[iť9rNy{Bb۰HG`~K% ܜEk< {rH,[U+ $ 'JG_*GƲxX2v#? Rσ߯-w*x"|1ya]xmgbhmA .sD$ˤ ,oujcTc0 n|w<͘#.{Qw1vٮPL"abgd~Lj| Two.OH\^s(4&&FTw'Z ;錠LȪiLLl\¬Ob$'2̀X"cV">&O$;4k23T_Aة!%7xE|I?0Kg@ĹxD5ڮ񷸦Y&g/׏r^C^;7ǖC&[ȴ̯ G/ FU/6%RYd#X ~AJ潱4Sz%& :yL`{ꙹxƎC?'*[$*ȣn"[h?pַ`YZW}Fiu vw0a@-VJKTF,I(eh]V%EtވG@QKw  2 8FYP!;ٙHHգ!D)Dߤ١v)8g̮akyxf}h[Fs'#Wx`+83ݮHloMvTn*XJ/YO,m.|wTʹVhǾܥS{ˇh@g5<$ 2Je/&x>`X,"hcŲNŎ:J>Q dx%˃?k~A +ܫ;{P#P2 76VzëgzyuwׯNk__Mx#ձTQBח׿Tktz꧳54!̦=بe=$C|$G'g7y-x.m

Videos

AJLM Symposium:
"Marketing Health: The Growing Role of Commercial Speech Doctrine in FDA Regulation" - Afternoon Sessions
February 26, 2011

>>Event details

  • Potentially Misleading Speech, Including Off-Label Promotion, Part 1
    • Aaron Kesselheim, Harvard School of Public Health & Brigham and Women's Hospital
      • Off Label Drug Use and Promotion: Balancing Public Health Goals and Commercial Speech
    • Martin Reddish, Northwestern University School of Law & Coleen Klasmeier, Sidley Austin
      • Off-Label Prescription Advertising, The FDA and The First Amendment: A Study in the Values of Commercial Speech Protection
  • Potentially Misleading Speech, Including Off-Label Promotion, Part 2
    • Christopher Robertson, University of Arizona James E. Rogers School of Law
      • Triple Blinding: How to Stop Undue Industry Influence on Biomedical Science, WIthout Violating the First Amendment
    • Kate Greenwood, Seton Hall Law Center for Health and Pharmaceutical Law & Policy
      • Preventive Medicine: A Constitutional Defense of the FDA's Wholesale Regulation of Prescription Drug Promotion